These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11028454)

  • 1. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients.
    Carrascosa A; Gussinyé M; Terradas P; Yeste D; Audí L; Vicens-Calvet E
    J Bone Miner Res; 2000 Oct; 15(10):2005-10. PubMed ID: 11028454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
    Costa AM; Lemos-Marini SH; Baptista MT; Morcillo AM; Maciel-Guerra AT; Guerra G
    J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low areal bone mineral density values in adolescents and young adult turner syndrome patients increase after long-term transdermal estradiol therapy.
    Gussinyé M; Terrades P; Yeste D; Vicens-Calvet E; Carrascosa A
    Horm Res; 2000; 54(3):131-5. PubMed ID: 11357006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turner syndrome and osteoporosis: mechanisms and prognosis.
    Rubin K
    Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
    Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
    Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.
    Hasegawa Y; Ariyasu D; Izawa M; Igaki-Miyamoto J; Fukuma M; Hatano M; Yagi H; Goto M
    Endocr J; 2017 Feb; 64(2):221-227. PubMed ID: 27916781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry.
    Högler W; Briody J; Moore B; Garnett S; Lu PW; Cowell CT
    J Clin Endocrinol Metab; 2004 Jan; 89(1):193-9. PubMed ID: 14715849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.
    Quigley CA; Wan X; Garg S; Kowal K; Cutler GB; Ross JL
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1754-64. PubMed ID: 24762109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimizing estrogen treatment in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 2003 Mar; 144(12):563-8. PubMed ID: 12723527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turner syndrome adolescents receiving growth hormone are not osteopenic.
    Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
    J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
    Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis].
    Lurati A; Cimaz R; Gattinara M; Gerloni V; Teruzzi B; Salmaso A; Fantini F
    Reumatismo; 2008; 60(3):224-9. PubMed ID: 18854886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
    Theintz G; Buchs B; Rizzoli R; Slosman D; Clavien H; Sizonenko PC; Bonjour JP
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1060-5. PubMed ID: 1400871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near Adult Height in Girls with Turner Syndrome Treated with Growth Hormone Following Either Induced or Spontaneous Puberty.
    Lanes R; Lindberg A; Carlsson M; Chrysis D; Aydin F; Camacho-Hübner C; King D; Davenport M
    J Pediatr; 2019 Sep; 212():172-179.e1. PubMed ID: 31227282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E; Mazzanti L
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.